Explore evidence

Gold tier: mechanically validated evidence, with its primary source.

1,030 evidence items · page 4 / 42

Following an initial drop, the malaria diagnosis rate gradually and concavely increased to a peak above pre-pandemic levels in Lambaréné, Gabon, based on observational data from two tertiary referral hospitals spanning 2018 to early 2023.

Gabonpaludismeobserved 2018 to early 2023published 2025International journal of epidemiologyeurope_pmcdocument of 5 observations

0 %The prevalence of pfhrp3 single deletions was 0% in the Republic of Congo.

Gabonpaludismepublished 2023Pathogens (Basel, Switzerland)europe_pmcdocument of 9 observationsDOI 10.3390/pathogens12030455

14 %Falls of hemoglobin concentrations of ≥2 g/dl occurred in 7 out of 51 patients (14%) in a study of fosmidomycin plus clindamycin for uncomplicated Plasmodium falciparum malaria in pediatric outpatients aged 1 to 14 years.

Gabonpaludismepublished 2006Antimicrobial agents and chemotherapyeurope_pmcdocument of 8 observations

0 ib/p/nThe nightly entomological inoculation rate (EIR) of Anopheles arabiensis was 0.0 infectious bites per person per night in Ntoula.

Gabonpaludismeobserved June to September 2022published 2024Parasites & vectorseurope_pmcdocument of 12 observations

24.1 %Malaria prevalence increased to 24.1% in Libreville, 6.5% in Port-Gentil, and 44.2% in Oyem in 2011.

Gabonpaludismeobserved 2011published 2013Malaria journaleurope_pmcdocument of 7 observations

76.2 %Moderate to severe anaemia was found in 76.2% of those co-infected with intestinal parasitic infections and P. falciparum.

Gabonintestinal parasitic infections · moderate to severe anaemia · paludismeobserved 2015–2016published 2020Transactions of the Royal Society of Tropical Medicine and Hygieneeurope_pmcdocument of 18 observations

6.8 %Jaundice occurred in 6.8% of severe malaria cases among children living in semi-rural areas in southeastern Gabon in 2019.

Gabonpaludismeobserved 2019published 2023BMC infectious diseaseseurope_pmcdocument of 14 observations

43 %Plasmodium vivax accounted for 43% of neonatal malaria cases.

Gabonpaludismepublished 2025BMC infectious diseasesPubMeddocument of 17 observations

93.38 %Among 70 malaria-positive patient samples screened for polymorphism in Libreville, Gabon, the AG mutation in Pfdhps occurred in 93.38% (n = 62) of samples.

Gabonpaludismepublished 2023Malaria journalPubMeddocument of 11 observations

20.5 %The proportion of wild type pfmdr1 86N allele reached 20.5% in 2008.

Gabonpaludismeobserved 2008published 2014Transactions of the Royal Society of Tropical Medicine and Hygieneeurope_pmcdocument of 5 observations

6.6 %Co-infection of malaria with Schistosoma infection prevalence was 6.6% among school-aged children in Gabon.

Gabonpaludismeobserved 2021published 2024Tropical medicine and infectious diseaseeurope_pmcdocument of 8 observationsDOI 10.3390/tropicalmed10010011

128 casesOf 689 malaria inpatients, 128 were adolescents in 2021.

Gabonpaludismeobserved 2021published 2024International Journal of Contemporary PediatricsOpenAlexdocument of 10 observationsDOI 10.18203/2349-3291.ijcp20241286

Chez les enfants non porteurs d’APOE Ɛ4, il n’y avait pas de réduction quantitative des densités parasitaires de Plasmodium spp. pour le phénotype HbAS par rapport au phénotype HbAA.

GabonpaludismeHAL · Unilimdocument of 81 observations

2.61 odds_ratioChildren aged 5–10 years had higher odds of malaria (OR: 2.61, 95% CI: [1.07–7.02]; p = 0.03) compared to younger children.

Gabonpaludismeobserved September and October 2022published 2026International journal of infectious diseases : IJID : official publication of the InternatPubMeddocument of 7 observations

89 %Atovaquone/proguanil treatment efficacy is 89%–98% for Plasmodium falciparum malaria.

Gabonpaludismepublished 2018The Journal of antimicrobial chemotherapyPubMeddocument of 4 observations

75 %Three quarters (75.0%) of severe malaria cases were in children less than 5 years of age.

Gabonpaludismepublished 2023Malaria journaleurope_pmcdocument of 25 observationsDOI 10.1186/s12936-023-04512-7

10 g/dlThe median Hb level was 10.0 g/dl in the presence of Plasmodium falciparum.

Gabonpaludismeobserved 2015–2016published 2020Transactions of the Royal Society of Tropical Medicine and Hygieneeurope_pmcdocument of 18 observations

1.43 %In 2019, each of the mutant pfcrt haplotypes CVINK, CVMEK, CVMNT, CVIEK, and CVIKK was detected in 1.43% of Plasmodium falciparum clinical isolates from Libreville, Gabon.

Gabonpaludismeobserved 2019published 2026Acta tropicaPubMeddocument of 13 observations

96.3 %The day 28 cure rate for Plasmodium ovale wallikeri infections was 96.3%.

Gabonpaludismepublished 2022The Lancet. MicrobePubMeddocument of 5 observations

20 %The prevalence of quadruple mutants IRN-A was 20.0%.

Gabonpaludismeobserved 2016published 2021Journal of global antimicrobial resistanceeurope_pmcdocument of 12 observations

49 %Severe anemia was the most frequent clinical sign of severe malaria in children in southeastern Gabon in 2019, occurring in 49.0% of cases.

Gabonpaludismeobserved 2019published 2023BMC infectious diseaseseurope_pmcdocument of 14 observations

1.17 odds_ratio_per_10_percent_increaseIL-5 circumsporozoite protein (CSP) ratios correlated with higher odds of malaria in RTS,S/AS01E vaccinees, with an odds ratio of 1.17 per 10% increase of CSP ratios.

Gabonpaludismepublished 2017Clinical infectious diseases : an official publication of the Infectious Diseases Society PubMeddocument of 2 observations

18 casesEighteen puerperal women had Plasmodium falciparum parasitemia, compared with 6 control women.

Gabonpaludismepublished 2005The Journal of infectious diseaseseurope_pmcdocument of 6 observations

Mosquito populations from Lambaréné and Zilé were resistant to pyrethroids and organochlorides.

Gabonpaludismepublished 2023Malaria journaleurope_pmcdocument of 3 observationsDOI 10.1186/s12936-023-04820-y

0.4 per_person_yearThe incidence of the first or only episode of clinical malaria in the intention-to-treat population was 0.40 per person-year in the control group during the 14 months after the first dose.

Gabonpaludismepublished 2012The New England journal of medicineeurope_pmcdocument of 6 observations

Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.